EHAB

NYSE Healthcare

Enhabit, Inc. Common Stock

Medical Care Facilities

Enhabit, Inc. provides home health and hospice services in the United States. The Home Health segment offers nursing care; physical, occupational, and speech therapy; medical and social work; and home health aide services. This segment also provides patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care, and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery or injury, and respiratory diseases; and counseling for patients and their families regarding financial, personal, and social concerns that arise from a patient's health-related problems. Its Hospice segment offers nursing care; pain and symptom management; palliative and dietary counseling; social worker visits; spiritual counseling; and family member bereavement counseling to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is headquartered in Dallas, Texas.

๐Ÿ“Š Market Data
Price$13.75
Volume956,292
Market Cap704.35M
Beta1.080
RSI (14-Day)17.1 Oversold
200-Day MA$9.95
50-Day MA$13.68
52-Week High$14.22
52-Week Low$6.47
Forward P/E22.14
Price / Book1.31
๐ŸŽฏ Investment Strategy Scores

EHAB scores across each investment strategy. Higher is better for that strategy's goals.

๐Ÿ’ฐ Dividend Daddy 23/100โ–ผ -1
High dividend yield + low volatility
๐Ÿš€ Moon Shot 89/100โ–ผ -2
High growth potential (high beta + oversold)
๐Ÿ”ช Falling Knife 68/100โ–ผ -5
Contrarian plays (oversold + below moving average)
Large-cap, institutional-quality stocks
๐Ÿ” Strategy Interpretation

Best fit: ๐Ÿš€ Moon Shot (89/100) โ€” this strategy High growth potential (high beta + oversold).

Lowest fit among scored strategies: ๐Ÿ‹ Institutional Whale (19/100). No single score is a buy or sell signal โ€” use multiple lenses together. Learn how to read these scores โ†’

Find EHAB in your text

Paste any article, transcript, or post โ€” the tool will extract EHAB and every other hidden ticker.

Try the Ticker Extractor โ†’

Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.